Efficacy and safety of sunitinib in previously treated, advanced non-small cell lung cancer (NSCLC): Preliminary results of a multicenter phase II trial.

被引：0
|
作者：
Socinski, M. A.
Novello, S.
Sanchez, J. M.
Brahmer, J. A.
Govindan, R.
Belani, C. P.
Atkins, J. N.
Gillenwater, H. H.
Palleres, C.
Chao, R. C.
机构：
[1] Univ N Carolina, Chapel Hill, NC 27515 USA
[2] Univ Turin, I-10124 Turin, Italy
[3] Hosp Germans Trias & Pujol, Barcelona, Spain
[4] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[5] Washington Univ, Sch Med, St Louis, MO USA
[6] Univ Pittsburgh, Sch Med, Pittsburgh, PA 15260 USA
[7] SE Med Oncol, Goldsboro, NC USA
[8] Univ Virginia, Charlottesville, VA USA
[9] Hosp San Pablo, Barcelona, Spain
[10] Pfizer, La Jolla, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：364S / 364S
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of sunitinib in a multicenter phase II trial of previously treated, advanced non-small cell lung cancer (NSCLC)
    Socinski, Mark A.
    Novello, Silvia
    Sanchez, Jose M.
    Brahmer, Julie
    Govindan, Ramaswamy
    Belani, Chandra P.
    Atkins, James N.
    Gillenwater, Heidi H.
    Palleres, C.
    Chao, Richard C.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 218 - 218
  • [2] Efficacy and safety of continuous daily sunitinib dosing in previously treated advanced non-small cell lung cancer (NSCLC): Results from a phase II study
    Brahmer, J. R.
    Govindan, R.
    Novello, S.
    Rosell, R.
    Belani, C. P.
    Atkins, J. N.
    Gillenwater, H. H.
    Tye, L.
    Chao, R.
    Socinski, M. A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [3] Multicenter, phase II trial of sunitinib in previously treated, advanced non-small-cell lung cancer
    Socinski, Mark A.
    Novello, Silvia
    Brahmer, Julie R.
    Rosell, Rafael
    Sanchez, Jose M.
    Belani, Chandra P.
    Govindan, Ramaswamy
    Atkins, James N.
    Gillenwater, Heidi H.
    Pallares, Cinta
    Tye, Lesley
    Selaru, Paulina
    Chao, Richard C.
    Scagliotti, Giorgio V.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (04) : 650 - 656
  • [4] Efficacy and safety of patupilone in non-small cell lung cancer (NSCLC):: A phase I/II trial.
    Sanchez, J. M.
    Mellemgaard, A.
    Perry, M.
    Zatloukal, P.
    Hamm, J.
    Belani, C. P.
    Kim, E.
    Felip, E.
    Berton, M.
    Johri, A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 390S - 390S
  • [5] Phase II study investigating the efficacy and safety of conti nuous daily sunitinib dosing in previously treated advanced non-small cell lung cancer (NSCLC)
    Govindan, R.
    Brahmer, J. R.
    Novello, S.
    Roseli, R.
    Belani, C. P.
    Atkins, J. N.
    Gillenwater, H. H.
    Tye, L.
    Chao, R. C.
    Socinski, M. A.
    [J]. EJC SUPPLEMENTS, 2007, 5 (04): : 365 - 365
  • [6] Safety and efficacy of nivolumab plus recombinant human endostatin in previously treated advanced non-small cell lung cancer: A prospective and multicenter phase 2 trial.
    Lv, Weize
    Zhong, Beilong
    Zhao, Wenhua
    Lin, Zhong
    Pei, Xiaofeng
    Wang, Zhihui
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [7] A phase II trial of denileukin difititox- in previously treated, advanced non-small cell lung cancer (NSCLC).
    Lewis, MAG
    Shukla, R
    Kleykamp, B
    Jazieh, AR
    Hainsworth, J
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 689S - 689S
  • [8] A phase II trial of denileukin diftitox in patients with previously treated advanced non-small cell lung cancer (NSCLC).
    Lewis, MAG
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 653S - 653S
  • [9] Docetaxel and Exisulind in previously treated non-small cell lung cancer (NSCLC) patients: A multicenter, phase II clinical trial
    Weiss, Glen J.
    Vokes, Everett E.
    Bunn, Paul A., Jr.
    Magree, Lyn
    Rusk, Jason
    Albert, Don
    Kelly, Karen
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (10) : 933 - 938
  • [10] Phase II pharmacodynamic trial of erlotinib in advanced non-small cell lung cancer (NSCLC) patients previously treated with platinum-based chemotherapy: preliminary results
    Ross, HJ
    Blumenschein, GR
    Dowlati, A
    Aisner, J
    Rigas, JR
    Stanislaus, M
    Leopold, LH
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 645S - 645S
12345